2578-5826

Immunological Medicine

Informa UK (Taylor & Francis)

View prefix report (10.1080)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 301 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact301 DOIs
2

Attach ORCID iDs across 123 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact123 DOIs
3

Deposit reference lists for 3 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact3 DOIs

DOIs for this ISSN

Showing the top 5 of 301 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Memory T cell, exhaustion, and tumor immunity (10.1080/25785826.2019.1698261)
Abstract ORCID
114.61 195
2 New insights into IFN-γ in rheumatoid arthritis: role in the… (10.1080/25785826.2020.1751908)
Abstract ORCID
97.22 87
3 LRG is a novel inflammatory marker clinically useful for the… (10.1080/13497413.2018.1481582)
Abstract ORCID
92.56 70
4 Blood–brain barrier dysfunction in immuno-mediated neurologi… (10.1080/25785826.2018.1531190)
Abstract ORCID
90.98 65
5 Systemic lupus erythematosus and immunodeficiency (10.1080/25785826.2019.1628466)
Abstract ORCID
90.65 64
6 T follicular helper cell subsets: a potential key player in… (10.1080/25785826.2020.1776079)
Abstract ORCID
88.54 58
7 Regulation of T cell differentiation by the AP-1 transcripti… (10.1080/25785826.2021.1872838)
Abstract ORCID
87.79 56
8 JAK inhibitors for the treatment of rheumatoid arthritis (10.1080/25785826.2020.1770948)
Abstract ORCID
85.38 50
9 Treatment with indigo naturalis for inflammatory bowel disea… (10.1080/25785826.2019.1599158)
Abstract ORCID
84.51 48
10 Basic mechanism of immune system activation by mitochondria (10.1080/25785826.2020.1756609)
Abstract ORCID
84.51 48
11 Clinical significance of myositis-specific autoantibodies (10.1080/25785826.2018.1531188)
Abstract ORCID
83.14 45
12 Diversity of neuropsychiatric manifestations in systemic lup… (10.1080/25785826.2020.1770947)
Abstract ORCID
80.64 40
13 Familial Mediterranean fever: overview of pathogenesis, clin… (10.1080/13497413.2018.1481579)
Abstract ORCID
80.10 39
14 Protein kinase 2 (CK2): a potential regulator of immune cell… (10.1080/25785826.2020.1843267)
Abstract ORCID
78.41 36
15 The role of nailfold videocapillaroscopy in patients with sy… (10.1080/25785826.2018.1531189)
Abstract ORCID License
78.10 10
16 Cow milk exosomes activate NK cells and γδT cells in human P… (10.1080/25785826.2020.1791400)
Abstract ORCID
75.93 32
17 Study on hypoxia-inducible factor and its roles in immune sy… (10.1080/25785826.2021.1910187)
Abstract ORCID
75.93 32
18 The effectiveness of adalimumab treatment for non-infectious… (10.1080/25785826.2019.1642080)
Abstract ORCID
75.26 31
19 New insights into the metabolism of Th17 cells (10.1080/25785826.2022.2140503)
Abstract ORCID
75.26 31
20 Dipeptidyl peptidase IV inhibitor-associated bullous pemphig… (10.1080/25785826.2019.1619233)
Abstract ORCID
73.86 29
21 Role of eosinophils in protective immunity against secondary… (10.1080/25785826.2019.1697135)
Abstract ORCID
73.12 28
22 Interleukin-6 plays a crucial role in the development of sub… (10.1080/09114300.2018.1451609)
Abstract ORCID
72.36 27
23 Chronic active Epstein–Barr virus infection: a bi-faceted di… (10.1080/25785826.2018.1556030)
Abstract ORCID
69.90 24
24 Autoimmune gastrointestinal dysmotility: the interface betwe… (10.1080/25785826.2020.1797319)
Abstract ORCID
69.01 23
25 Towards the era of immune checkpoint inhibitors and personal… (10.1080/25785826.2020.1785654)
Abstract ORCID
68.09 22
26 The impact of maternal exposure to antibiotics on the develo… (10.1080/25785826.2021.1963189)
Abstract ORCID
68.09 22
27 JAK inhibitors ∼ overview∼ (10.1080/25785826.2023.2183594)
Abstract ORCID
67.12 21
28 Immunometabolism in rheumatoid arthritis (10.1080/25785826.2018.1531186)
Abstract ORCID
65.05 19
29 Prognostic value of IL-34 in colorectal cancer patients (10.1080/25785826.2019.1691429)
Abstract ORCID
65.05 19
30 CXCL13-producing PD-1<sup>hi</sup>CXCR5<sup>−</sup> helper T… (10.1080/25785826.2020.1781998)
Abstract ORCID
65.05 19
31 Era of steroid sparing in the management of immune-mediated… (10.1080/09114300.2018.1451593)
Abstract ORCID
63.94 18
32 Myositis an evolving spectrum of disease (10.1080/13497413.2018.1481571)
Abstract ORCID
62.76 17
33 A case of nivolumab-associated colitis, which relapsed after… (10.1080/25785826.2019.1580477)
Abstract ORCID
62.76 17
34 Dynamics and clinical significance of intestinal intraepithe… (10.1080/25785826.2019.1658516)
Abstract ORCID
61.52 16
35 Future trends in the treatment of atopic dermatitis (10.1080/25785826.2019.1628467)
Abstract ORCID
60.21 15
36 B-cell depletion therapy for multiple sclerosis (10.1080/25785826.2021.1952543)
Abstract ORCID
60.21 15
37 Evaluation of disease activity in uveoretinitis associated w… (10.1080/25785826.2020.1800244)
Abstract ORCID
58.80 14
38 Recent progress of JAK inhibitors for hematological disorder… (10.1080/25785826.2022.2139317)
Abstract ORCID
58.80 14
39 Recent advances in the role of RNA-binding protein, tristetr… (10.1080/25785826.2018.1531187)
Abstract ORCID License
58.36 5
40 Predicting therapeutic response in IgG4-related disease base… (10.1080/09114300.2018.1451613)
Abstract ORCID
57.31 13
41 Comparison of fluorescence optical imaging, ultrasonography… (10.1080/13497413.2018.1481578)
Abstract ORCID
57.31 13
42 Current standardized therapeutic approach for uveitis in Jap… (10.1080/25785826.2019.1678961)
Abstract ORCID
57.31 13
43 Multicenter, observational clinical study of abatacept in Ja… (10.1080/25785826.2019.1605036)
Abstract ORCID
55.70 12
44 Proteogenomics: advances in cancer antigen research (10.1080/25785826.2019.1640500)
Abstract ORCID
55.70 12
45 Recent findings regarding the effects of microRNAs on fibrob… (10.1080/25785826.2019.1695490)
Abstract ORCID
55.70 12
46 ‘Narrow-sense’ and ‘broad-sense’ vascular abnormalities of s… (10.1080/25785826.2020.1754692)
Abstract ORCID
55.70 12
47 Clinical usefulness of anti-M-type phospholipase-A-receptor… (10.1080/25785826.2019.1710079)
Abstract ORCID
53.96 11
48 Clinical manifestations in anti-Ro52/SS-A antibody-seroposit… (10.1080/25785826.2021.1919342)
Abstract ORCID
53.96 11
49 ARID5B is a negative modulator of IL-6 production in rheumat… (10.1080/25785826.2024.2346956)
Abstract ORCID
52.07 10
50 Diagnosis and treatment of autoinflammatory diseases in adul… (10.1080/25785826.2018.1524105)
Abstract ORCID
50.00 9